Login to Your Account

BMS After ImClone; Offers $60 per Share for Erbitux Partner

By Jennifer Boggs

Friday, August 1, 2008
On the heels of Roche Holdings AG's $44 billion offer for Genentech Inc., as potentially the biggest buyout bid in the industry, another big pharma has made a play for its biotech collaborator. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription